Resources from the same session
1O - A prognostic value of BCT gene score in ER+HER2- breast cancer patients with 21-gene recurrence score
Presenter: Sung Gwe Ahn
Session: Proffered Paper session: Breast cancer
Resources:
Abstract
Slides
Webcast
36O - <sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) PET/CT guided first-line treatment for HR+/HER2- metastatic breast cancer patients: Experience from real-world
Presenter: Biyun Wang
Session: Proffered Paper session: Breast cancer
Resources:
Abstract
Slides
Webcast
Invited discussant 1O and 36O
Presenter: Lucia Del Mastro
Session: Proffered Paper session: Breast cancer
Resources:
Slides
Webcast
27O - Assessment of overall survival benefit from neoadjuvant chemotherapy in elderly HER-2 negative breast cancer patients: A population-based study
Presenter: Wenjie Lv
Session: Proffered Paper session: Breast cancer
Resources:
Abstract
Slides
Webcast
2O - Analysis of Asian and non-Asian patients (pts) from the NATALEE trial of ribociclib (RIB) + a nonsteroidal aromatase inhibitor (NSAI) in pts with HR+/HER2− early breast cancer (EBC)
Presenter: Yen-Shen Lu
Session: Proffered Paper session: Breast cancer
Resources:
Abstract
Slides
Webcast